|
2024
|
Invention
|
Pyrimidinyl tyrosine kinase inhibitors.
The present invention provides compounds and composition... |
|
|
Invention
|
Glycogen synthase kinase 3 inhibitors and uses thereof. The present disclosure provides compounds... |
|
|
Invention
|
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors.
Described herein are compou... |
|
|
Invention
|
Methods of treating or preventing spinal muscular atrophy.
Featured are methods for the treatmen... |
|
|
Invention
|
Compounds and methods for reducing tau expression.
Provided are compounds, methods, and pharmace... |
|
|
Invention
|
Combination of a btk inhibitor and a fumaric acid ester for use in the treatment of multiple scle... |
|
|
Invention
|
Btk inhibitor for treating multiple sclerosis. The present disclosure provides methods of treatin... |
|
|
Invention
|
Immunosuppressive regimens and methods thereof. Among other things, the present disclosure provid... |
|
|
Invention
|
1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (... |
|
|
Invention
|
Methods of recombinant adeno-associated virus (raav) production. Aspects of the present disclosur... |
|
|
Invention
|
Engineered cells and cell lines for aav production and methods of making and using the same. The ... |
|
|
Invention
|
Packaging plasmids for aav production. The present disclosure provides improved packaging plasmid... |
|
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof. The present disclosure provides anti-trans... |
|
|
Invention
|
Rgd-containing peptides for delivering payloads. The present disclosure pertains to muscle-target... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthal... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of psychiatric ... |
|
2023
|
Invention
|
Methods of treating inflammatory and autoimmune diseases.
Natalizumab is a safe and efficacious ... |
|
|
Invention
|
Nrf2 activator.
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereo... |
|
|
Invention
|
Cyclooctene compositions and uses thereof. The present disclosure provides a compound of Formula ... |
|
|
Invention
|
Bruton's tyrosine kinase inhibitors.
The present invention provides compounds useful as inhibito... |
|
|
Invention
|
Implantable cranial medical device.
An implantable cranial medical device includes a housing con... |
|
|
Invention
|
Compositions and methods for modulation of smn2 splicing in a subject.
Disclosed herein are comp... |
|
|
Invention
|
Compositions and methods for treating retinitis pigmentosa. Among other things, the present discl... |
|
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof.
The present disclosure provides anti-tran... |
|
|
Invention
|
Systems and methods for classification of lesions and for predicting lesion development. Disclose... |
|
|
Invention
|
Methods for classification of lesions and for predicting lesion development.
Disclosed are syste... |
|
|
Invention
|
Ask1 inhibiting agents.
Provided are compounds of Formula (I):
Provided are compounds of Formu... |
|
|
Invention
|
Compounds for treating huntington's disease. The present disclosure provides a compound of Formul... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof. Provided are compounds of the Formula (I): ... |
|
|
Invention
|
Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof.
The invention is direct... |
|
|
Invention
|
Pharmaceutical compositions containing anti-beta amyloid antibodies.
Pharmaceutical compositions... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
use in the treatment of psychiatric... |
|
|
Invention
|
Anti-vla-4 antibodies.
This invention relates to alpha-4 binding antibodies, and fragments thereof. |
|
|
G/S
|
Computer software for neuro-psychology tests; computer software for use to detect neurological di... |
|
2022
|
Invention
|
Method for detecting a lipidated protein via fluorescence resonance energy transfer (fret).
Aspe... |
|
|
Invention
|
Methods for treating alzheimer's disease.
Provided are methods for treating Alzheimer's disease ... |
|
|
Invention
|
Diroximel fumarate particles having improved flow properties and methods of making same.
Many ac... |
|
|
G/S
|
Medical apparatus and instruments, namely, auto injection devices for pharmaceuticals |
|
|
Invention
|
Compounds for targeting degradation of irak4 proteins.
This disclosure relates to compounds of F... |
|
|
Invention
|
Synthetic preparation for diroximel fumarate.
Disclosed is a method of preparing diroximel fumar... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of eye
diseases, disorders, and conditions; ophtha... |
|
|
Invention
|
Compounds for targeting degradation of bruton's tyrosine kinase.
This disclosure relates to comp... |
|
|
Invention
|
Compositions and methods for treating chronic active white matter lesions / radiologically isolat... |
|
|
Invention
|
Combination treatment methods of multiple sclerosis.
The present disclosure provides combination... |
|
|
Invention
|
Nucleic acid delivery to the central nervous system.
Featured are polymeric nanocarriers (e.g., ... |
|
|
Invention
|
Treatment of amyotrophic lateral sclerosis.
The disclosure provides the use of neurofilament lig... |
|
|
Invention
|
Reducing host cell impurities during recombinant protein production.
In some instances, the appl... |
|
|
G/S
|
Medical diagnostic reagents and assays for testing of body fluids |
|
|
Invention
|
Microtubule destabilizer additives to increase recombinant viral vector titers.
The present disc... |
|
|
Invention
|
Tyk2 inhibitors.
This disclosure relates to compounds of formula (I′), or pharmaceutically accep... |
|
2021
|
Invention
|
Imidazo[1,2-a]pyridine derivatives as irak4 inhibitors and their use in the treatment of disease.... |
|
|
G/S
|
Providing medical and health information in the field of neurology and neurologic disorders. |
|
|
Invention
|
Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitors.
Provided are compounds of Formula (I′): o... |
|
|
Invention
|
Btk inhibitors.
Provided are compounds of Formula (I): or pharmaceutically acceptable salts ther... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis and other neurolog... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis |
|
|
G/S
|
Providing medical and health information in the field of neurology and neurologic disorders |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
neurological disorders; pharmaceutical preparat... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparati... |
|
|
G/S
|
Providing educational information, webcasts, and training materials in the fields of health, medi... |
|
2020
|
G/S
|
Pharmaceutical preparations for the treatment of neurologic disorders Providing medical and healt... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparation... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological and neurodegenerative diseases. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of choroidal diseases and disorders; pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of choroidal diseases and disorders; Pharmaceutical... |
|
|
G/S
|
Providing webcasts in the fields of health, medical conditions, and treatments; development and d... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic
lateral sclerosis and other neurolo... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders, namely, Alzheimer's Dise... |
|
|
G/S
|
Providing medical information in the field of neuromuscular diseases. |
|
|
G/S
|
Providing health information in the field of inflammatory disorders, namely, providing patient su... |
